What is one of the goals of Phase 2 clinical trials?

One of the primary goals of Phase 2 clinical trials is to obtain preliminary data on the drug's effectiveness for a specific disease. During this phase, researchers assess how well the drug works in individuals who have the targeted condition. This phase typically involves a larger group of participants than Phase 1 trials and is designed to focus on evaluating the drug's efficacy in a real-world scenario.

Phase 2 trials are crucial because they help establish whether the drug shows promise for treating the disease, which guides decisions about moving forward to Phase 3 trials. In addition to effectiveness, Phase 2 trials may also begin to assess safety and dosage, but the primary outcome is to determine if the drug has a beneficial effect on the disease in question.

This phase does not focus on marketing strategies, patterns of absorption and elimination, or long-term side effects to the same extent as other phases, which clarifies why obtaining data on effectiveness is the correct answer within the context of clinical trial objectives.